Sitemap

December 10, 2003 Articles

Filter by Available Specialty
  1. Aggressive lipid lowering may lead to regression of hard exudates
  2. B&L secures exclusive rights to AREDS formula
  3. Better visual outcomes seen from earlier ROP treatment
  4. Patient compliance, quality of life added to European glaucoma guidelines